Cite
Hwang JE, Ki MS, Kim K, et al. The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis. Oncotarget. 2017;8(39):66559-66568doi: 10.18632/oncotarget.16301.
Hwang, J. E., Ki, M. S., Kim, K., Jung, S. H., Shim, H. J., Bae, W. K., Hwang, E. C., Hur, Y. H., Jeong, O., Ryu, S. Y., Park, Y. K., Cho, S. H., Lee, J. S., & Chung, I. J. (2017). The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis. Oncotarget, 8(39), 66559-66568. https://doi.org/10.18632/oncotarget.16301
Hwang, Jun Eul, et al. "The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis." Oncotarget vol. 8,39 (2017): 66559-66568. doi: https://doi.org/10.18632/oncotarget.16301
Hwang JE, Ki MS, Kim K, Jung SH, Shim HJ, Bae WK, Hwang EC, Hur YH, Jeong O, Ryu SY, Park YK, Cho SH, Lee JS, Chung IJ. The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis. Oncotarget. 2017 Mar 16;8(39):66559-66568. doi: 10.18632/oncotarget.16301. eCollection 2017 Sep 12. PMID: 29029536; PMCID: PMC5630436.
Copy
Download .nbib